Mount Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,838
Closed -$2.23M 30
2023
Q1
$2.23M Buy
4,838
+92
+2% +$43.8K 0.88% 28
2022
Q4
$2.44M Buy
+4,746
New +$2.41M 0.94% 20

Other funds holding ELV

Mount Capital's ELV Position: Q2 2023 in Review

Mount Capital sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 4,838 shares — an estimated $2.23M sold.

Mount Capital first reported a position in ELV in Q4 2022 and held it in 2 quarters. The position peaked at $2.44M in Q4 2022. 1,524 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Mount Capital reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Mount Capital sold 4,838 Elevance Health shares in Q2 2023, an estimated $2.23M.
  • Mount Capital first reported a position in Elevance Health in Q4 2022 and held it in 2 quarters.
  • Mount Capital's Elevance Health position peaked at $2.44M in Q4 2022.
  • 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Mount Capital's 13F filing for Q2 2023, filed 14 Aug 2023.